Nervous System Neoplasms: Clinical Trials

4,096 trials for Nervous System Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1788 completed, 693 recruiting, 485 unknown, 440 terminated. 1292 Phase 2, 969 Phase 1, 801 Not applicable, 316 Phase 3, 105 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 21292Completed 592, Terminated 186, Recruiting 181, Unknown 129, Active not recruiting 95, Withdrawn 60, Not yet recruiting 40, Suspended 7, Enrolling by invitation 2
Phase 1969Completed 491, Recruiting 141, Terminated 140, Active not recruiting 78, Withdrawn 45, Unknown 38, Not yet recruiting 26, Suspended 7, Enrolling by invitation 3
Not applicable801Completed 289, Recruiting 181, Unknown 123, Terminated 61, Active not recruiting 46, Not yet recruiting 45, Withdrawn 40, Enrolling by invitation 8, Suspended 8
Phase 3316Completed 146, Recruiting 46, Unknown 44, Active not recruiting 32, Terminated 29, Not yet recruiting 10, Withdrawn 7, Enrolling by invitation 2
Early Phase 1105Completed 36, Recruiting 19, Terminated 18, Not yet recruiting 12, Withdrawn 8, Active not recruiting 7, Unknown 4, Enrolling by invitation 1
Phase 475Completed 35, Unknown 15, Recruiting 11, Terminated 4, Active not recruiting 3, Withdrawn 3, Enrolling by invitation 2, Not yet recruiting 2

Follow Nervous System Neoplasms: new trials by email Literature Review of Nervous System Neoplasms trials Research Report on Nervous System Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
RNS System Implantation - Glioma, Glioma Intracranial
Not applicableNot yet recruitingMedical College of Wisconsin32028-08-012026-10-13
Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma
JBI-778 - Brain Metastases From Solid Tumors, Leptomeningeal Disease
Phase 1 / Phase 2Not yet recruitingJubilant Therapeutics Inc.1132028-04-012026-08-07
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Aminolevulinic acid hydrochloride - Pediatric Brain Tumor
Phase 2Not yet recruitingCostas Hadjipanayis202027-08-012026-10-07
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
H3K27M-EIEs - Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-10-30
Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
Non-Interventional Study - Brain Tumor, Recurrent Brain Tumor
Not yet recruitingMayo Clinic302027-06-012026-09-16
Plasma Pyrophosphate Imbalance According to Phenotype and Bone Remodelling Alterations in Type 1 Neurofibromatosis - PIRATE-NF1 -
Neurofibromatosis 1 (NF1), Plexiform Neurofibromas (NFP)
Not yet recruitingUniversity Hospital, Angers402027-04-092026-11-18
Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
Myasthenia Gravis Generalized
Not yet recruitingBioSensics252027-03-152026-10-13
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG
Opdualag - High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2Not yet recruitingNationwide Children's Hospital122027-03-012026-09-09
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Tovorafenib - High Grade Glioma (HGG) of the Brain With BRAF Aberration, High Grade Glioma (III or IV)
Phase 2Not yet recruitingNationwide Children's Hospital792027-02-012026-10-20
IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas
IDH1-vac, IS-vac, Temozolomide (TMZ) - Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4
Phase 2Not yet recruitingGerman Cancer Research Center2162027-02-012026-10-22
Blood Brain Barrier Dysfunction in Glioma and Epileptogenesis
Epilepsy, Glioma
Not yet recruitingUniversity College, London562027-01-042026-11-02
Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults
Mirdametinib - LGCMN, Large and Giant Congenital Melanocytic Nevi
Phase 2Not yet recruitingNational Cancer Institute (NCI)152027-01-042026-10-29
Ceritinib Treatment for Recurrent Meningiomas
Ceritinib - Recurrent Meningioma, Grade I and Grade II
Phase 2Not yet recruitingKevin Petrecca102027-01-012026-10-23
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Trastuzumab Deruxtecan, Stereotactic Radiosurgery - Breast Cancer, HER2-positive Breast Cancer
Phase 1Not yet recruitingBaptist Health South Florida202027-01-012026-10-01
Role of ChatGPT in Vestibular Schwannoma Management
Use of chatGPT for 1 week - Vestibular Schwannoma
Not applicableWithdrawnUniversity of Southern California2027-01-012026-01-13
Listen Aphasia Pilot Study
LISTEN (AI-based AAC smartphone app) - Aphasia, Malignant Brain Tumor
Not applicableNot yet recruitingDana-Farber Cancer Institute802027-01-012026-07-28
A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar Spine
3D-printed custom-made non-rigid biomimetic implant - Spinal Tumor
Not applicableNot yet recruitingNational Taiwan University Hospital182027-01-012025-12-17
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
CSF ctDNA-Guided Clinical Management - Leptomeningeal Disease, Glioblastoma
Not applicableNot yet recruitingAlireza Mansouri772027-01-012026-07-08
DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial)
Dexmedetomidine, Normal Saline (0.9% NaCl) - Neurosurgery, Brain Cancer
Not applicableNot yet recruitingUniversity of Malaya602027-01-012026-11-05
rTMS for Postoperative Brain Tumor Patients
Transcranial magnetic stimulation (TMS) - Brain Tumors, Transcranial Magnetic Stimulation
Not applicableRecruitingBrian J.Gill62027-01-012026-10-29

Showing 20 of 4096. Sign in to see all of them.

Narrower conditions

Brain Neoplasms (2375)  ·  Glioblastoma (734)  ·  Central Nervous System Neoplasms (696)  ·  Glioma (599)  ·  Astrocytoma (454)  ·  Gliosarcoma (364)  ·  Myasthenia Gravis (321)  ·  Oligodendroglioma (310)  ·  Neoplasms (261)  ·  Meningioma (242)  ·  Breast Neoplasms (224)  ·  Medulloblastoma (208)  ·  Carcinoma, Non-Small-Cell Lung (196)  ·  Pituitary Neoplasms (192)  ·  Sarcoma (177)

Broader conditions

Nervous System Diseases (4076)  ·  Neoplasms by Site (3944)  ·  Neoplasms (3835)  ·  Central Nervous System Diseases (2907)  ·  Brain Diseases (2795)  ·  Central Nervous System Neoplasms (2734)  ·  Neoplasms by Histologic Type (1997)  ·  Neoplasms, Nerve Tissue (1818)  ·  Neuroectodermal Tumors (1543)  ·  Neoplasms, Germ Cell and Embryonal (1537)  ·  Neoplasms, Glandular and Epithelial (1404)  ·  Neoplasms, Neuroepithelial (1299)  ·  Glioma (649)  ·  Pathological Conditions, Signs and Symptoms (615)

Interventions

Temozolomide (260)  ·  Radiotherapy (234)  ·  Radiosurgery (152)  ·  Bevacizumab (129)  ·  Magnetic Resonance Spectroscopy (117)  ·  Carboplatin (92)  ·  Cyclophosphamide (76)  ·  Etoposide (68)  ·  Filgrastim (60)  ·  Vincristine (58)  ·  Cisplatin (54)  ·  Irinotecan (54)  ·  Nivolumab (50)  ·  Radiation (47)  ·  Surgical Procedures, Operative (47)

Sponsors

National Cancer Institute (NCI) (235)  ·  M.D. Anderson Cancer Center (115)  ·  Duke University (80)  ·  Memorial Sloan Kettering Cancer Center (77)  ·  Children's Oncology Group (52)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (51)  ·  Mayo Clinic (50)  ·  St. Jude Children's Research Hospital (46)  ·  European Organisation for Research and Treatment of Cancer - EORTC (42)  ·  Massachusetts General Hospital (37)  ·  Case Comprehensive Cancer Center (33)  ·  Jonsson Comprehensive Cancer Center (30)  ·  Novartis Pharmaceuticals (30)  ·  City of Hope Medical Center (29)  ·  Beijing Tiantan Hospital (27)

Countries

United States (2323)  ·  China (404)  ·  Canada (347)  ·  France (342)  ·  Germany (239)  ·  Italy (223)  ·  United Kingdom (206)  ·  Spain (170)  ·  Netherlands (161)  ·  Australia (134)  ·  Belgium (128)  ·  Switzerland (117)  ·  South Korea (100)  ·  Denmark (93)  ·  Poland (92)

Top investigators

Henry S. Friedman, MD (19)  ·  Brigitte C Widemann, M.D. (14)  ·  Stuart A. Grossman, MD (13)  ·  David A. Reardon, MD (11)  ·  John Boockvar, MD (10)  ·  Maryam Fouladi, MD (10)  ·  Amar Gajjar, MD (9)  ·  Jeffrey J. Raizer, MD (9)  ·  Darell D. Bigner, MD, PhD (8)  ·  Katherine E Warren, M.D. (8)  ·  Roger Stupp, MD (8)  ·  David Peereboom, MD (7)

Results publications

PMID 31401903, PMID 34081125, PMID 19801201, PMID 16757720, PMID 23545055, PMID 25349290, PMID 27243238, PMID 27458945, PMID 30118397, PMID 31809241, PMID 35007270, PMID 37059507, PMID 41213248, PMID 42388397, PMID 14722039, PMID 15117425, PMID 15758009, PMID 16200343, PMID 16648043, PMID 17705175, PMID 17917842, PMID 19556464, PMID 19574236, PMID 19645909, PMID 20694800, PMID 21041710, PMID 21211990, PMID 21584645, PMID 21865400, PMID 22027076, PMID 23243055, PMID 23377664, PMID 23956241, PMID 25098701, PMID 25113840, PMID 25209242, PMID 25303679, PMID 25614945, PMID 25789053, PMID 26148750, PMID 26247776, PMID 26334749, PMID 26827696, PMID 27488294, PMID 27744512, PMID 28039367, PMID 28592387, PMID 28640703, PMID 29077941, PMID 29122701

NIH funding

2023 (29), P30CA033572 (18), U01CA062475 (17), U10CA180886 (17), U01CA081457 (16), U10CA098543 (16), 2019 (14), 2025 (14), 2018 (13), 2015 (12), P30CA043703 (12), 2014 (11), P30CA006973 (11), P30CA138292 (11), UM1CA097452 (11)